Genomics,Multiomics

Dataset Information

Homo sapiens


ABSTRACT: NCIC CTG MA.22 phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer on 2-weekly or 3-weekly schedules

PROVIDER: PRJNA278663 | ENA |

REPOSITORIES: ENA